Abstract
In this study, we propose a framework for assessing the economic value of condoms and provide estimates of the potential societal savings, in the form of decreased HIV-related medical care and lost productivity costs, that accrue from use of condoms. A probabilistic model of HIV transmission was used to estimate reductions in HIV risk attributable to condom use. This estimate was combined with an estimate of the cost to society of a single case of HIV infection to determine a lower bound for the potential societal savings associated with condom use. Several condom use scenarios were considered (including multiple uses with a single partner and multiple uses with multiple partners) for each of three populations: low-risk heterosexuals, high-risk heterosexuals, and men who have sex with men. The savings exceeded the estimated cost of producing and distributing condoms in all but one of the scenarios considered. For multiple condom uses, the per-condom savings ranged from about 50¢ for low-risk heterosexuals to over $500 for multi-partnered men who have sex with men.
Similar content being viewed by others
REFERENCES
Abramson, P. R., and Pinkerton, S. D. (1995). With pleasure: Thoughts on the nature of human sexuality. New York: Oxford University Press.
Bloom, D. E., and Carliner, G. (1988). The economic impact of AIDS in the United States. Science, 239, 604–610.
Brookmeyer, R., and Gail, M. H. (1994). AIDS epidemiology: A quantitative approach. New York: Oxford University Press.
Carpenter, C. C. J., Fischl, M. A., Hammer, S. M., Hirsch, M. S., Jacobsen, D. M., Katzenstein, D. A., Montaner, J. S. G., Richman, D. D., Saag, M. S., Schooley, R. T., Thompson, M. A., Vella, S., Yeni, P. G., and Volberding, P. A. (1996). Antiretroviral therapy for HIV infection in 1996: Recommendations of an international panel. Journal of the American Medical Association, 276, 146–154.
Carpenter, C. C. J., Fischl, M. A., Hammer, S. M., Hirsch, M. S., Jacobsen, D. M., Katzenstein, D. A., Montaner, J. S. G., Richman, D. D., Saag, M. S., Schooley, R. T., Thompson, M. A., Vella, S., Yeni, P. G., and Volberding, P. A. (1998). Antiretroviral therapy for HIV infection in 1998: Recommendations of an international panel. Journal of the American Medical Association, 280, 78–86.
Catz, S. L., and Kelly, J. A. (in press). Living with HIV disease. In A. Baum and J. Singer (Eds.), Handbook of health psychology. Hillsdale, NJ: Erlbaum.
Centers for Disease Control and Prevention. (1997). Update: Trends in AIDS incidence, deaths, and prevalence—United States, 1996. Morbidity and Mortality Weekly Reports, 46, 165–173.
Chapman, S., and Hodgson, J. (1988). Showers in raincoats: Attitudinal barriers to condom use in high-risk heterosexuals. Community Health Studies, 12, 97–105.
Choi, K.-H., and Catania, J. A. (1996). Changes in multiple sexual partnerships, HIV testing, and condom use among US heterosexuals 18 to 49 years of age, 1990 to 1992. American Journal of Public Health, 86, 554–556.
Choi, K.-H., Rickman, R., and Catania, J. A. (1994). What heterosexual adults believe about condoms. New England Journal of Medicine, 331, 406–407.
Deeks, S. G., Smith, M., Holodniy, M., and Kahn, J. O. (1997). HIV-1 protease inhibitors: A review for clinicians. Journal of the American Medical Association, 277, 145–153.
Drummond, M. F., O'Brien, B. Stoddart, G. L., and Torrance, G. W. (1997). Methods for the economic evaluation of health care programmes, Second Ed. New York: Oxford University Press.
Eng, T. R., and Butler, W. T. (1997). The hidden epidemic: Confronting sexually transmitted diseases. Washington, DC: National Academy Press.
Gold, M. R., Siegel, J. E., Russell, L. B., and Weinstein, M. C. (Eds.). (1996). Cost-effectiveness in health and medicine. New York: Oxford University Press.
Guinan, M. E., Farnham, P. G., and Holtgrave, D. R. (1994). Estimating the value of preventing a human immunodeficiency virus infection. American Journal of Preventive Medicine, 10, 1–4.
Haddix, A. C., and Shaffer, P. A. (1996). Cost-effectiveness analysis. In A. C. Haddix, S. M. Teutsch, P. A. Shaffer, and D. O. Duñet (Eds.), Prevention effectiveness: A guide to decision analysis and economic evaluation. New York: Oxford University Press.
Hardy, A. M., Rausch, K., Echenberg, D., Morgan, W. M., and Curran, J. W. (1986). The economic impact of the first 10,000 cases of acquired immunodeficiency syndrome in the United States. Journal of the American Medical Association, 255, 209–211.
Hearst, N., and Hulley, S. B. (1988). Preventing the heterosexual spread of AIDS. Journal of the American Medical Association, 259, 2428–2432.
Hellinger, F. J. (1993). The lifetime cost of treating a person with HIV. Journal of the American Medical Association, 270, 474–478.
Hodgson, T. A. (1994). Cost of illness in cost-effectiveness analysis: A review of the methodology. Pharmacoeconomics, 6, 536–552.
Holmberg, S. D. (1996). The estimated prevalence and incidence of HIV in 96 large US metropolitan areas. American Journal of Public Health, 86, 642–654.
Holtgrave, D. R., and Kelly, J. A. (1996). Preventing HIV/AIDS among high-risk urban women: The cost-effectiveness of a behavioral group intervention. American Journal of Public Health, 86, 1442–1445.
Holtgrave, D. R., and Kelly, J. A. (1997). The cost-effectiveness of an HIV prevention intervention for gay men. AIDS and Behavior, 1, 173–180.
Holtgrave, D. R., and Pinkerton, S. D. (1997). Updates of cost of illness and quality of life estimates for use in economic evaluations of HIV prevention programs. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 16, 54–62.
Holtgrave, D. R., and Pinkerton, S. D. (1998). The cost-effectiveness of small group and community-level interventions. In D. R. Holtgrave (Ed.), Handbook of economic evaluation of HIV prevention programs (pp. 120–127). New York: Plenum Press.
Holtgrave, D. R., and Pinkerton, S. D. (in press). The economics of HIV primary prevention. In J. L. Peterson and R. J. DiClemente (Eds.), Handbook of HIV prevention. New York: Plenum Press.
Kahn, J. G., and Haynes-Sanstad, K. C. (1997). The role of cost-effectiveness analysis in assessing HIV prevention interventions. AIDS and Public Policy Journal, 12, 21–30.
Kaplan, E. H. (1990). Modeling HIV infectivity: Must sex acts be counted? Journal of Acquired Immune Deficiency Syndromes, 3, 55–61.
Katz, M. H., and Gerberding, J. L. (1997). Postexposure treatment of people exposed to the human immunodeficiency virus through sexual contact or injection-drug use. New England Journal of Medicine, 336, 1098–1100.
Kelly, J. A., St. Lawrence, J. S., Hood, H. V., and Brasfield, T. L. (1989). Behavioral interventions to reduce AIDS risk activities. Journal of Consulting and Clinical Psychology, 57, 60–67.
Mastro, T. D., and de Vincenzi, I. (1996). Probabilities of sexual HIV-1 transmission. AIDS, 10(Suppl. A), S75-S82.
Murphy, J. S. (1990). The condom industry in the United States. Jefferson, NC: McFarland.
Philipson, T., and Dow, W. H. (1998). Infectious disease transmission and infection-dependent matching. Mathematical Biosciences, 148, 161–180.
Pinkerton, S. D., and Abramson, P. R. (1992). Is risky sex rational? The Journal of Sex Research, 29, 561–568.
Pinkerton, S. D., and Abramson, P. R. (1993). Evaluating the risks: A Bernoulli process model of HIV infection and risk reduction. Evaluation Review, 17, 504–528.
Pinkerton, S. D., and Abramson, P. R. (1994). An alternative model of the reproductive rate of HIV infection: Formulation, evaluation, and implications for risk reduction interventions. Evaluation Review, 18, 371–388.
Pinkerton, S. D., and Abramson, P. R. (1996). Occasional condom use and HIV risk reduction. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 13, 456–460.
Pinkerton, S. D., and Abramson, P. R. (1997a). Condoms and the prevention of AIDS. American Scientist, 85, 364–373.
Pinkerton, S. D., and Abramson, P. R. (1997b). Effectiveness of condoms in preventing HIV transmission. Social Science and Medicine, 44, 1303–1312.
Pinkerton, S. D., and Abramson, P. R. (1998). The Bernoulli-process model of HIV transmission: Applications and implications. In D. R. Holtgrave (Ed.), Handbook of economic evaluation of HIV prevention programs. New York: Plenum Press.
Pinkerton, S. D., and Holtgrave, D. R. (1998). Assessing the cost-effectiveness of HIV prevention interventions: A primer. In D. R. Holtgrave (Ed.), Handbook of economic evaluation of HIV prevention programs (pp. 34–44). New York: Plenum Press.
Pinkerton, S. D., Holtgrave, D. R., DiFranceisco, W. J., Stevenson, L. Y., and Kelly, J. A. (1998a). Cost-effectiveness of a community-level HIV risk reduction intervention. American Journal of Public Health, 88, 1239–1242.
Pinkerton, S. D., Holtgrave, D. R., Leviton, L. C., Wagstaff, D. A., and Abramson, P. R. (1998b). Model-based evaluation of HIV prevention interventions. Evaluation Review, 22, 155–174.
Pinkerton, S. D., Holtgrave, D. R., and Valdiserri, R. O. (1997). Cost-effectiveness of HIV prevention skills training for men who have sex with men. AIDS, 11, 347–357.
Rabkin, J. G., and Ferrando, S. (1997) A 'second life’ agenda. Archives of General Psychiatry, 54, 1049–1053.
Reiss, I. L., and Leik, R. K. (1989). Evaluating strategies to avoid AIDS: Number of partners vs. use of condoms. Journal of Sex Research, 26, 411–433.
Rice, D. P. (1967). Estimating the cost of illness. American Journal of Public Health, 57, 424–440.
Rice, D. P., and Max, W. (1996). Appendix I: Productivity loss tables. In A. C. Haddix, S. M. Teutsch, P. A. Shaffer, and D. O. Duñet (Eds.), Prevention effectiveness: A guide to decision analysis and economic evaluation. New York: Oxford University Press.
Royce, R. A., Seña, A., Cates, W. Jr., and Cohen, M. S. (1997). Sexual transmission of HIV. New England Journal of Medicine, 336, 1072–1078.
Russell, L. B. (1986). Is prevention better than cure? Washington DC: The Brookings Institute.
Scitovsky, A. A., and Rice, D. P. (1987). Estimates of the direct and indirect costs of acquired immunodeficiency syndrome in the United States, 1985, 1986, and 1991. Public Health Reports, 102, 5–17.
Tao, G., and Remafedi, G. (1998). Economic evaluation of an HIV prevention intervention for gay and bisexual male adolescents. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 17, 83–90.
Wagstaff, D. A., Pinkerton, S. D., Abramson, P. R., Holtgrave, D. R., and Leviton, L. C. (1999). Estimating the impact of sexually transmitted HIV prevention interventions: A comparison of the proportion of unprotected acts to a regression-based approach. AIDS and Behavior, 3, 129–133.
Weinstein, M. C., Graham, J. D., Siegel, J. E., and Fineberg, H. V. (1989). Cost-effectiveness analysis of AIDS prevention programs: Concepts, complications, and illustrations. In C. F. Turner, H. G. Miller, and L. E. Moses (Eds.), AIDS: Sexual behavior and intravenous drug use (pp. 471–499). Washington, DC: National Academy Press.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Pinkerton, S.D., Abramson, P.R. & Holtgrave, D.R. What Is a Condom Worth?. AIDS Behav 3, 301–312 (1999). https://doi.org/10.1023/A:1025485301438
Issue Date:
DOI: https://doi.org/10.1023/A:1025485301438